Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

GoHealth (GOCO) Other Non Operating Income (2019 - 2025)

GoHealth (GOCO) has disclosed Other Non Operating Income for 7 consecutive years, with -$2.2 million as the latest value for Q4 2025.

  • Quarterly Other Non Operating Income rose 97.52% to -$2.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.2 million through Dec 2025, up 69.03% year-over-year, with the annual reading at -$1.7 million for FY2025, 84.18% up from the prior year.
  • Other Non Operating Income hit -$2.2 million in Q4 2025 for GoHealth, down from -$1.7 million in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $77.4 million in Q3 2024 to a low of -$87.7 million in Q4 2024.
  • Historically, Other Non Operating Income has averaged -$1.5 million across 5 years, with a median of -$13000.0 in 2021.
  • Biggest YoY gain for Other Non Operating Income was 967.92% in 2024; the steepest drop was 237245.95% in 2024.
  • Year by year, Other Non Operating Income stood at -$11.9 million in 2021, then surged by 99.46% to -$65000.0 in 2022, then soared by 156.92% to $37000.0 in 2023, then crashed by 237245.95% to -$87.7 million in 2024, then surged by 97.52% to -$2.2 million in 2025.
  • Business Quant data shows Other Non Operating Income for GOCO at -$2.2 million in Q4 2025, -$1.7 million in Q3 2025, and -$11000.0 in Q2 2025.